STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
OTHER INCOME	$ 67,157	$ 15,405	$ 180,301	$ 30,405
OPERATING EXPENSES:
Research and development (6 months excluding R&D depreciation of $83,391 and $160,820, respectively, included below and 3 months excluding R&D depreciation of $41,718 and $55,957, respectively, included below)	4,153,998	2,515,585	8,173,539	5,439,363
Depreciation and amortization	51,444	90,413	108,143	223,863
General & administrative	2,088,150	1,649,231	4,059,364	3,650,516
Total operating expenses	6,293,592	4,255,229	12,341,046	9,313,742
OPERATING LOSS	(6,226,435)	(4,239,824)	(12,160,745)	(9,283,337)
(LOSS) GAIN ON DERIVATIVE INSTRUMENTS	(7,132,348)	3,538,264	(5,521,531)	6,284,462
INTEREST INCOME	30,882	30,952	62,639	60,367
INTEREST EXPENSE	(37,679)	(42,763)	(80,361)	(85,109)
NET LOSS	(13,365,580)	(713,371)	(17,699,998)	(3,023,617)
ISSUANCE OF ADDITIONAL SHARES DUE TO RESET PROVISIONS			(1,117,447)	0
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (13,365,580)	$ (713,371)	$ (18,817,445)	$ (3,023,617)
NET LOSS PER COMMON SHARE
BASIC	$ (0.24)	$ (0.02)	$ (0.36)	$ (0.10)
DILUTED	$ (0.24)	$ (0.14)	$ (0.36)	$ (0.31)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	56,239,562	30,901,177	52,183,654	29,592,161
DILUTED	56,239,562	30,901,177	52,183,654	29,592,161